Mechanism of Action

Fisetin is a naturally occurring flavonoid that demonstrates multiple therapeutic mechanisms at the molecular and cellular level, though the evidence base is still developing.

Anti-inflammatory and Neuroprotective Pathways

Research indicates that fisetin modulates key neuroinflammatory, oxidative stress, and autophagy pathways in neurodegenerative disorders. In laboratory studies using amyotrophic lateral sclerosis (ALS) cell models, fisetin prevented deterioration of cellular functions in cells containing specific protein variants (G262R and P438L of SQSTM1), suggesting it may help maintain cellular integrity under pathological conditions.

Hepatoprotective Mechanisms

In mouse models of liver injury, fisetin appears to work through two primary molecular pathways:

TGF-β1/Smad3 pathway modulation: This pathway is involved in fibrosis and tissue scarring
p53/Bax/Bcl-2 pathway regulation: These proteins control programmed cell death (apoptosis)

The modulation of these pathways suggests fisetin may help protect liver cells from toxic damage and prevent excessive cell death.

Cancer Cell Effects

Laboratory studies suggest fisetin may affect cancer cell proliferation through multiple mechanisms:

Interference with cell cycle progression leading to growth arrest
Potential modulation of microRNA (miRNA) and long non-coding RNA (lncRNA) expression profiles
When formulated as glucose-capped silver nanoparticles, it appears to disrupt protein expression patterns in breast cancer cells

Senolytic Properties

Emerging research suggests fisetin may have senolytic effects, meaning it could selectively target and eliminate senescent (aged and dysfunctional) cells. This mechanism is being investigated for its potential role in addressing age-related conditions including frailty and ovarian aging, though the specific molecular pathways involved require further clarification.

Limitations and Clinical Translation

While laboratory studies show promising molecular mechanisms, the clinical evidence remains limited. Several clinical trials investigating fisetin for conditions including COVID-19, frailty, and osteoarthritis have been terminated, withdrawn, or suspended, indicating challenges in translating laboratory findings to human applications.

Disclaimer: This information is for educational purposes only and should not be used as medical advice. Consult healthcare providers before using fisetin or any supplement for therapeutic purposes.